It starts with a vial, but not just any vial
Made from enhanced Type I borosilicate glass, EVERIC® pure vials feature a homogenous inner surface for improved drug stabilty, delamination protection and lower leachable levels. They help to speed your way to market by reducing the need for reformulations and improving patient safety.
Designed for use with challenging fills, such as biologics, diluents and vaccines, we recommend EVERIC® pure as your first consideration for all new projects to ensure the best chance of success*.
Some benefits of using EVERIC® pure vials for your project:
- Reduced risk of pH shifts through improved vial surface
- Unmatched drug stability for low-fill volumes
- Minimised leachables helping to maintain the integrity of sensitive drug formulations
- Protection against delamination, in high-risk low-fill drug products
- Compliant with all current standards, including Ph. Eur, USP, JP and CP
EVERIC® pure vials are available from stock at Adelphi in sizes 2R, 6R and 10R, with an EBB (European blowback) neck finish. Other sizes, from 3R to 50R are available for special order.
Join the webinar
Join us as Diana Löber from SCHOTT Pharma explains the risks posed by Glass Delamination in Low-fill Drugs, in our live webinar, dated ******
This exclusive webinar will discuss:
The 'critical zone' of a vial which holds the greatest risk
Why low-fill drugs are more prone to delamination
The serious risk to patient safety should glass delamination occur
How to can mitigate the risk and move to market with confidence
Register today...and the final step
* Please note
For certain formulation and process challenges, such as an alkaline pH or liquids for lyophilisation, alternative vials may offer better outcomes.
Our knowledgable team can help you to select the right container-closure solution for your specific project.
Request a free consultation